Maybe AI touches your deliverables. Maybe AI runs through the middle of how your company works. Either way, your pharma client's diligence questionnaire is already asking questions your sales deck cannot answer. Three hours to build the story, the evidence, and the judgment to walk into that conversation prepared instead of hopeful.
Get My Seat, $499$499 per seat. Live session, workbook, and your evidence register, started on your real offering.
Here is how providers lose pharma deals now, and it is rarely because the technology is weak. The buyer loses confidence because the provider cannot explain the intended use, the data, the evidence, or the human accountability behind their AI story. Sales says one thing, Product says another, Security says a third, and the diligence call exposes all three at once.
The questionnaires keep getting longer, and they are reaching everyone: companies selling AI products, and companies that simply use AI in how they deliver. If you have not seen the AI section yet, it is coming; getting ahead of it is the entire advantage.
A sponsor does not buy your model. They buy the ability to see: what your AI is for, what it must never do, what evidence stands behind each claim, and who is accountable when the answer is uncertain. Showing your work is not a defensive posture; it is the fastest trust-building move available to a provider, and the providers who master it make the buyer's job easier than their competitors do. "I do not know, and here is how I will find out" closes more deals than a perfect demo.
We can teach this from both chairs, because one of us spent a decade as the buyer, building the oversight rubrics your questionnaire descends from, and the other is a provider answering those questionnaires at top-20 pharma companies right now, this quarter.
What "approved" does and does not mean, how buyers translate your AI answers into risk tiers, and why the same claim needs different evidence depending on what your AI touches: a deliverable, a workflow, or a decision.
You start your minimum viable evidence register on your real offering, using the same AI-assisted build pattern we teach pharma teams, so the artifact and the skill arrive together. Then the green, amber, red claims guardrail that gets Sales, Product, and Security telling one story.
We walk a fictional provider through a full diligence exchange, question by question, with a former pharma buyer narrating what each answer does to her confidence, and you map every move onto your own claims. You leave knowing which of your answers are green today, and exactly what your 30-day evidence sprint looks like.




One of us wrote the questions. One of us is answering them right now. You get the buyer's real logic and the provider's live playbook in the same three hours, from two people who have sat on both sides of the table you are about to walk up to.
Founders, BD and sales leaders, product managers, security and privacy leads, quality leads, and delivery owners at CROs, agencies, data and AI companies, and consultancies that serve pharma. You belong here if AI touches what you deliver or how you deliver it, and you have a live pharma relationship or a serious plan to build one inside 12 months.
Not for you if: you have no target buyer yet (start with our free masterclass instead), or you want a lawyer's compliance opinion (we teach judgment and evidence, not legal advice).
| Seat | Price |
|---|---|
| Single seat | $499 |
| Team, up to 5 seats | $1,795 |
| Each extra seat beyond 5 | $349 |
| VIP: the Diligence Dossier | $899 |
Bringing your team? The team price exists so that nobody has to choose between doing the right thing and doing the affordable thing. Five seats for $1,795 works out at $359 each, and every person gets their own login, their own build, and their own workbook instead of watching over a colleague's shoulder. Beyond five, extra seats are $349 each.
What VIP buys: the Diligence Dossier, prepared for your company alone. You submit your real claims and evidence register through a secure intake. You get back a written dossier that sorts every claim green, amber, or red, names the question a pharma buyer will ask about each one, states the evidence that moves it to green, and marks the gaps that stall deals. With it comes a recorded walkthrough, read the way a buyer reads it. Ten business days. VIP also carries the replay of the bootcamp itself.
Private on purpose. Your material is never worked in a room with other companies, and a competitor sitting in the main session never hears a word of it.
The live session is not recorded for standard seats. The room stays a room, which matters more here than anywhere: nobody works their real weak points in a session that is being taped. VIP is the only way to get the replay.
We made this a document rather than a meeting for a reason. A call is one hour and then it is gone. A dossier is something your whole team carries into the real diligence process, and the recording is what you replay the night before the call that matters.
Every seat includes the live session, the workbook, and your started evidence register. The work happens live, hands on keyboard, and that is the point. Every seat also includes a free membership in The AI Builders Circle, our year-round community and the ongoing home for providers building AI maturity. The VIP replay lives there, in a private classroom.
Against a six-figure pharma deal, this is the cheapest rehearsal you will ever run.
There is no universal "approved for pharma" badge, and anyone selling you one is the reason diligence exists. We do not and cannot promise that deals stop stalling or that any buyer says yes; implementation is yours, and accountability for your claims stays with you, which is rather the point of the whole discipline. What we promise is the tools, the insider insight, and the rehearsal: bounded claims, inspectable evidence, and one consistent answer from every seat on your team.
One more insider note, free: sponsors have started asking providers not just whether they use AI, but how the efficiency shows up in rates and hours. The providers who can answer that question with a straight face and a clear story are having very different renewal conversations than the ones who cannot. That is the level this bootcamp is aimed at.
And the reason we built any of this: the evidence you produce ends up inside somebody else's submission, somebody else's protocol, somebody else's decision about a person who is waiting. Getting good at this work is how that person waits less.
The people at the end of it are also us.


Need the justification for your leadership? Download the letter.
Your next diligence conversation is coming either way. Walk in with your work ready to show.
Get My Seat, $499 Team of 5, $1,795Built for people working inside pharma and biotech. Friday, November 13.
See that bootcampOne hour, no cost, and the best way to see how we teach before you spend anything. Friday, November 6.
Save a free seatThe bootcamp runs live once, and standard seats are not recorded. Tell us and you will hear first when the next one is scheduled.
Join the waitlist